Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression

BACKGROUND: Benralizumab can be utilized as add-on biological treatment of severe eosinophilic asthma. However, so far only a few real-life studies have been published with regard to the use of this anti-IL-5 receptor humanized monoclonal antibody. OBJECTIVE: The primary aim of this multicenter obse...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Asthma Allergy
Main Authors: Pelaia, Corrado, Crimi, Claudia, Benfante, Alida, Caiaffa, Maria Filomena, Calabrese, Cecilia, Carpagnano, Giovanna Elisiana, Ciotta, Domenico, D’Amato, Maria, Macchia, Luigi, Nolasco, Santi, Pelaia, Girolamo, Pellegrino, Simona, Scichilone, Nicola, Scioscia, Giulia, Spadaro, Giuseppe, Valenti, Giuseppe, Vatrella, Alessandro, Crimi, Nunzio
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2021
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7910091/
https://ncbi.nlm.nih.gov/pubmed/33654413
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S297273
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados